Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Sky-Line Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacture, and marketing of ophthalmic medications. The company's portfolio includes a variety of eye drops and ointments for treating conditions such as glaucoma, cataracts, and ocular infections. Established in 1994, it has become a significant player in the regional ophthalmic market in China, operating from its GMP-certified facilities in the Shenyang Economic & Technological Development Zone. Its products, such as Pirenoxine Sodium and Levofloxacin eye drops, are widely used in clinical practice across China. The company focuses on providing high-quality, affordable eye care solutions to address the increasing prevalence of vision-related disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Sky.